LIVE

/Cosmic Eclipse/Charizard & Braixen-GX

Variants

MARGINAL · Conviction 4/10

Charizard & Braixen-GX

Cosmic Eclipse · #22 · Rare Holo GX

Live NM ask

€34.94

PSA 9

–

no graded data

PSA 10

–

no graded data

Composite

4.0

Updated 3 days ago

Cardmarket (EUR) →eBay (US) →

Buy range€22.72 – €29.71At market

All prices and projections are for Near Mint English-language cards. Other conditions and languages may vary significantly.

Price history

Ungraded NM PSA 9 PSA 10

No price history available for this card yet.

Investment thesis

Sub-score breakdown · ROI projections

4.0

SCORE / 10

Liquidity

0.0

Scarcity

0.0

Era potential

2.8

Friction

3.5

Hold-Raw · 5Y Outlook▲ PRIMARY

+•••%

Available with Pro

Grade or sell · per-card

Free account

See if grading this card pays.

How is this scored?

The composite score (0–10) blends signals across trust, set tier, era, liquidity, and price. The four sub-scores shown above (Liquidity, Scarcity, Era CAGR, Friction) describe each card across complementary axes; they share inputs with the composite but use different formulas. The Friction sub-score (added 2026-05-11) combines liquidity, price-spread stability, era maturity, and affordability minus a flat marketplace-fee proxy. The era-benchmark ROI numbers project returns based on the card's release era — they're not card-specific predictions. Limitations: the score is a relative ranking heuristic, not a forecast. Prices are snapshots and can drift between refreshes — always verify externally before buying.

Pop report

PSA 10 gem rate 47.03%Total population

PSA 10

11,670

PSA 9

9,173

PSA 8

2,371

Total graded

24,814

Gem rate 47.03%. Consistent with modern era gem rates; expect supply to grow as more are graded.

OVERVIEW

Investment summary

Charizard & Braixen-GX from the Cosmic Eclipse set (#22) currently trades at €34.94 in the raw market. By market value it ranks #33 of 272 in Cosmic Eclipse — the 90th percentile of the set. Market data is informational only and does not constitute investment advice.